Acorah Software Products - Accounts Production 15.0.600 false true 31 December 2022 1 May 2022 false 1 January 2023 31 December 2023 31 December 2023 14074601 Mr J E Powell Dr S A Black Dr E Sideso Dr P Finigan Uk Vein Clinic Ltd true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14074601 2022-12-31 14074601 2023-12-31 14074601 2023-01-01 2023-12-31 14074601 frs-core:CurrentFinancialInstruments 2023-12-31 14074601 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-01-01 2023-12-31 14074601 frs-core:OtherResidualIntangibleAssets 2023-12-31 14074601 frs-core:OtherResidualIntangibleAssets 2023-01-01 2023-12-31 14074601 frs-core:OtherResidualIntangibleAssets 2022-12-31 14074601 frs-core:PlantMachinery 2023-12-31 14074601 frs-core:PlantMachinery 2023-01-01 2023-12-31 14074601 frs-core:PlantMachinery 2022-12-31 14074601 frs-core:ShareCapital 2023-12-31 14074601 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 14074601 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 14074601 frs-bus:FilletedAccounts 2023-01-01 2023-12-31 14074601 frs-bus:SmallEntities 2023-01-01 2023-12-31 14074601 frs-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 14074601 frs-bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 14074601 1 2023-01-01 2023-12-31 14074601 frs-bus:Director1 2023-01-01 2023-12-31 14074601 frs-bus:Director2 2023-01-01 2023-12-31 14074601 frs-bus:Director3 2023-01-01 2023-12-31 14074601 frs-bus:Director4 2023-01-01 2023-12-31 14074601 frs-countries:EnglandWales 2023-01-01 2023-12-31 14074601 2022-04-30 14074601 2022-12-31 14074601 2022-05-01 2022-12-31 14074601 frs-core:CurrentFinancialInstruments 2022-12-31 14074601 frs-core:ShareCapital 2022-12-31 14074601 frs-core:RetainedEarningsAccumulatedLosses 2022-12-31
Registered number: 14074601
UK Vein Clinic (Thames Valley) Limited
Financial Statements
For The Year Ended 31 December 2023
Fairman Harris
ICAEW
1 Landor Road
London
SW9 9RX
Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 14074601
31 December 2023 31 December 2022
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 36,767 -
Tangible Assets 5 15,105 -
51,872 -
CURRENT ASSETS
Stocks 6 16,193 -
Debtors 7 301,876 66,215
318,069 66,215
Creditors: Amounts Falling Due Within One Year 8 (267,427 ) (53,898 )
NET CURRENT ASSETS (LIABILITIES) 50,642 12,317
TOTAL ASSETS LESS CURRENT LIABILITIES 102,514 12,317
NET ASSETS 102,514 12,317
CAPITAL AND RESERVES
Called up share capital 9 100 100
Profit and Loss Account 102,414 12,217
SHAREHOLDERS' FUNDS 102,514 12,317
Page 1
Page 2
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr J E Powell
Director
24 September 2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
UK Vein Clinic (Thames Valley) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14074601 . The registered office is First Floor, 150 Harley Street, London, W1G 7LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are start up costs. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 20% Straight Line
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2022: NIL)
- -
4. Intangible Assets
Other
£
Cost
As at 1 January 2023 -
Additions 39,795
As at 31 December 2023 39,795
Amortisation
As at 1 January 2023 -
Provided during the period 3,028
As at 31 December 2023 3,028
Net Book Value
As at 31 December 2023 36,767
As at 1 January 2023 -
5. Tangible Assets
Plant & Machinery
£
Cost
As at 1 January 2023 -
Additions 17,100
As at 31 December 2023 17,100
Depreciation
As at 1 January 2023 -
Provided during the period 1,995
As at 31 December 2023 1,995
Net Book Value
As at 31 December 2023 15,105
As at 1 January 2023 -
6. Stocks
31 December 2023 31 December 2022
£ £
Stock 16,193 -
Page 4
Page 5
7. Debtors
31 December 2023 31 December 2022
£ £
Due within one year
Prepayments and accrued income 4,725 -
Other debtors 297,102 66,166
Directors' loan accounts 49 49
301,876 66,215
8. Creditors: Amounts Falling Due Within One Year
31 December 2023 31 December 2022
£ £
Trade creditors 17,674 1,361
Corporation tax 23,093 2,866
Other creditors 210,425 27,791
Accruals and deferred income 16,235 21,880
267,427 53,898
9. Share Capital
31 December 2023 31 December 2022
£ £
Allotted, Called up and fully paid 100 100
10. Related Party Transactions
Uk Vein Clinic Ltd - intercompany balance: DB £297,102, (2022: £66,166)
Uk Vein Clinic Group Limited: CR £210,425 (2022: £27,791)
11. Ultimate Controlling Party
The company's ultimate controlling party is Uk Vein Clinic Ltd by virtue of its ownership of 51% of the issued share capital in the company.
Page 5